| Document Date: 2015-01-09 13:37:34
Open Document File Size: 1,18 MBShare Result on Facebook
Company United Therapeutics Corp. / / Currency pence / / Event Product Issues / FDA Phase / Product Recall / / IndustryTerm infusion site / subcutaneous infusion site / parenteral drug products / / MedicalCondition chest pain / headache / infusion site infection / pulmonary arterial hypertension / cellulitis / connective tissue diseases / nausea / chronic indwelling / blood stream infections / chronic dosing study / fatigue / chronic dosage adjustments / diarrhea / restlessness / serious blood stream infections / pruritus / Infections / moderate hepatic insufficiency / sepsis / hepatic insufficiency / hypotension / catheter-related line infections / abdominal pain / thrombophlebitis / jaw pain / disease / Catheter-Related Bloodstream Infection / dyspnea / Carcinogenesis / symptomatic hypotension / thrombocytopenia bone pain / erythema / pulmonary arterial hypertension requiring transition / vomiting / pain / Severe hepatic insufficiency / Renal Insufficiency / right ventricular heart failure / infection / dizziness / Catheter-Related Bloodstream Infection Chronic / rash / paresthesias / / MedicalTreatment Drug Delivery System / intravenous infusions / intravenous infusion / catheter / catheters / cannula / / Organization World Health Organization / Vasodilators Concomitant administration / DOSAGE AND ADMINISTRATION / FDA / / / Position General / Major / / Product acetaminophen / REMODULIN / Sodium Chloride / Flolan / Abrupt / gemfibrozil / Tracleer / rifampin / Risk of Catheter-Related Bloodstream Infection / fluconazole / Sterile Water for Injection / sterile water / glycine / / Technology Pharmacokinetics / drug delivery / Drug Delivery System / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
Remodulin PI Approved under S-020